We only have a rudimentary understanding of the molecular and cellular determinants of human nerve regeneration. Here, we use carpal tunnel syndrome (CTS) as a human model system to prospectively evaluate correlates of neural regeneration and their relationship with clinical recovery after decompression surgery. At 6 months post-surgery, we noted a significant improvement of median nerve neurophysiological and somatosensory function. Serial skin biopsies revealed a partial recovery of intraepidermal innervation, whose extent correlated with symptom improvement. In myelinated afferents, nodal length increased postoperatively.
Introduction
Knowledge of cellular and molecular correlates of nerve regeneration is critical to understand the temporal profile of nerve regeneration as well as the determinants of successful recovery. While neural regeneration has been extensively studied in animal models of peripheral nerve injury 1, 2 , studying the determinants of nerve regeneration and its relationship to recovery in humans remains challenging due to the limited access to tissues and a lack of treatments to promote nerve regeneration.
So far, studies have mostly relied on sensory or motor reinnervation times, the advancement of Tinel's sign as well as the recovery of action potentials in electrophysiological recordings 3 . In the past decade, serial skin biopsies have provided insights into the regeneration of small sensory axons in humans 4, 5, 6, 7 . Recently, skin biopsies have also been used to obtain information about the integrity of myelination and large nerve fibres 8, 9 . However, a lack of knowledge remains concerning the molecular and cellular determinants of nerve regeneration and their relationship to clinical recovery and specifically neuropathic pain in humans.
Here, we use carpal tunnel syndrome (CTS) as a model system to study sensory nerve regeneration in humans. CTS is one of the few neuropathic conditions that can be treated surgically. It therefore provides a unique model system to prospectively study the cellular and molecular correlates of nerve regeneration and their relationship to clinical recovery in humans.
We deeply phenotyped patients before and six months after carpal tunnel decompression including electrophysiology, quantitative sensory testing, symptom profile and functional deficits. Using serial skin biopsies, we determined the postoperative reinnervation of sensory target tissue with histology as well as the molecular signature associated with regeneration using RNA-sequencing. This revealed that ADCYAP1 was the most differentially expressed gene and the protein this gene encodes (PACAP) was found to enhance neurite outgrowth in human induced pluripotent stem cell-derived sensory neurones.
Results

The majority of patients show significant symptomatic and functional improvement
Sixty patients with electrodiagnostically confirmed CTS (mean age 62.5 (SD 12.2), 36 females) were examined before and six months after decompression surgery. Twenty healthy volunteers served as healthy controls. Baseline demographic and clinical data are presented in Table 1 . Postsurgically, 83.3% of patients rated their symptoms at least 'a good deal better' (≥5) on the global rating of change scale. None of the patients experienced a deterioration of symptoms. In relation to hand function, 63 .3% of operated patients felt at least 'a good deal better'. The self-perceived symptoms and function improvements were consistent with a post-operative decrease of the Boston carpal tunnel questionnaire symptom and function subscales (Boston symptoms mean (SD) pre 2.8 (0.7), post 1.5 (0.5), t (59)=13.8, p<0.0001; Boston function pre 2.2 (0.8), post 1.5 (0.5), t (59)=7.00, p<0.0001). However, symptoms did not fully resolve in all patients, with 46 .6% continuing to have some pain and 38.3% to feel paraesthesia or numbness, although these residual symptoms were mostly mild in nature. SNAP: sensory nerve action potential; NCV: nerve conduction velocity; CMAP: compound motor action potential; delay ulnar-median: delay between the motor potentials for dorsal interossei (ulnar nerve) and lumbricals (median nerve) measured over an 8cm wrist segment. P-values that were significant following Benjamini-Hochberg correction are highlighted in bold.
Sensory detection thresholds improve following surgery, but fail to reach normal levels
Quantitative sensory testing data from the median innervated territory of the hand can be found in 
Intraepidermal nerve fibres partially regenerate following surgery
Skin biopsies in the median nerve innervated territory of the hand showed a substantial structural degeneration of small axons in the epidermal layer of patients' skin compared to healthy controls (fibres/mm epidermis in CTS pre-operative mean (SD) 4.20 (2.83); healthy controls 8.03 (2.08), t(77)=5.3, p<0.0001, Figure 2A -C). Following surgery, intraepidermal nerve fibre density improved (5.35 (3.34) , t(57)=-3.5, p=0.001), but failed to reach normal innervation levels (t(77)=3.4, p=0.001). Of note, postoperative regeneration was highly variable ( Fig 2D) .
Subepidermal plexus nerve fibre length density remains unchanged
Given the incomplete epidermal reinnervation following surgery, we hypothesised that regenerating axons may reach the dermis but their penetration through the dermal-epidermal junction may be delayed 7, 10 . However, evaluation of nerve fibre length density in the subepidermal plexus did not reveal any differences in patients pre-and post-surgery (median Fig S1A) .
Nodal architecture changes following surgery
To evaluate changes in myelinated fibres, we examined nodal architecture which was previously found altered in patients with CTS (9) (Fig 2E-F Fig 2G-H) .
The density of Meissner corpuscles, the number of PGP+ axon bundles per mm 2 dermis and the ratio of dermal PGP+ axon bundles containing myelin remained unchanged at baseline and after surgery ( Fig S1B-D) .
Deterioration in small fibre integrity in patients not undergoing surgery
A small number of patients (n=13) opted not to undergo surgery. These were slightly younger and had less severe symptoms at baseline compared to those undergoing surgery (Table 1) . Of note, non-operated patients demonstrated a continuing degeneration of their IENFD over time (mean baseline 6.94 (SD 3.09); follow up 5.61 (3.41), t(12)=2.66, p=0.021, Fig 2D) . Data for the other clinical and histological measures of non-operated patients are summarized in Table S2 .
Neural regeneration correlates with symptom improvement
The extent of small fibre regeneration positively correlates with symptom improvement as determined with the Boston symptom questionnaire (r=0.389, p=0.001, Fig 2I) . A postoperative increase in nodal length (r=0.302, p=0.012, Fig 2J) and percentage of elongated nodes with GROC for hand function marginally failed to reach significance after Benjamini Hochberg correction (r=0.306, p=0.019). None of the other correlations were significant (p>0.144).
genes including ADCYAP1 are differentially expressed following surgery
To determine a molecular signature associated with nerve regeneration, we performed RNA sequencing of the skin of 47 patients with CTS (n=29 females) before and after surgical decompression. Thirty-one genes were significantly differentially expressed (DE) in CTS patients post-versus pre-surgery ( Fig 3A-B , Fig S2 , Table S3 ). Gene ontology enrichment analysis for biological processes showed that these genes were enriched amongst others in proximal/distal pattern formation ( Fig 3C, Table S4 ). The most significantly dysregulated gene was ADCYAP1 (log2 fold change =1.87, FDR p-value = 0.0001, Fig 3A) . ADCYAP1 encodes PACAP (pituitary adenylate cyclase-activating peptide), which is a highly evolutionary conserved protein that is involved in a range of physiological processes including neuronal survival after injury and neurite outgrowth 11 . We confirmed the increased expression of ADCYAP1 in skin samples following surgical release using the independent technique of droplet digital PCR ( Fig S3) .
Expression of DE genes is associated with histological evidence for nerve regeneration
We did not identify FDR adjusted significant correlations on the individual level between the RNA-sequencing-determined fold change of the 31 significantly DE genes and the 1) fold change or 2) differences in IENFD and mean nodal length post-surgery versus pre-surgery. We also defined four phenotypic groups (quarters) based on the continuous IENFD and nodal length fold change quartiles and tested for significant associations of these groups with baseline DE gene expression. Whereas no relationship was detected for nodal length, this analysis revealed that IENFD fold change quarters were significantly dependent on ADCYAP1, DLX1, PRKG2, ADHFE1, and PIK361 baseline expression (p<0.05). ADCYAP1 ( Fig 3D) and ADHFE1 are upregulated in all IENFD fold change quarters compared to the lowest quarter of patients with negative IENFD fold change, i.e. those who continue to degenerate. PRKG2 is upregulated and DLX1 and PIK3R6 are downregulated in patients belonging to the 3 rd and 4 th quarter.
PACAP is expressed in human skin and facilitates neurite outgrowth in vitro
We confirmed the localisation of PACAP within sensory afferents in human skin using immunohistochemistry ( Fig 4A) . Human induced pluripotent stem cell-derived (hiPSCd) sensory neurons have been shown to replicate many of the molecular, morphological and functional features of native human sensory neurons 12, 13, 14 and so we used these to study the functional effects of PACAP. These hiPSCd-sensory neurons demonstrated strong mRNA expression of both ADCYAP1, as well as its high affinity receptor PAC1 ( Fig 4B) . mRNA of the secondary receptors VPAC1 and VPAC2 with affinity for PACAP and VIP (vasoactive intestinal protein) are also expressed in hiPSCd-sensory neurons albeit at lower levels. We therefore used these neurons as an experimental in vitro model to explore a potential role of PACAP in neurite regeneration following axotomy. Immunostaining for PAC1 revealed that this was predominantly located in cell bodies and growth cones ( Fig 4C) , consistent with a role in promoting axon outgrowth. Application of 10 nM PACAP to hiPSCd-sensory neurons increased total neurite outgrowth length by 86% compared to vehicle (mean (SD) vehicle 570.9µm (181.8);
PACAP 1065.0µm (285.5), t(11)=3.79, p=0.003, Fig 4D-E) , confirming a pro-regenerative role of PACAP in human sensory neurons.
Discussion
Little is known about the molecular and cellular determinants of nerve regeneration in humans.
Using CTS as a model system, we demonstrate recovery of large and small fibre function following surgical nerve decompression; however, this recovery remains incomplete even 6 months after surgery. There was significant individual variation in the degree of cutaneous reinnervation, and at group level this did not reach the level seen in unaffected control individuals. We identified a significant correlation between both cutaneous reinnervation by small fibres and the nodal length of myelinated sensory fibres, with symptom and functional recovery following carpal tunnel decompression, respectively. Gene expression analysis identified 31 differentially expressed genes, with ADCYAP1 encoding PACAP being most strongly upregulated. Intriguingly, ADCYAP1 expression was associated with a histological regenerative phenotype and a regenerative role of PACAP was confirmed in hiPSCd-sensory neurons.
Carpal tunnel surgery greatly improved symptoms in the majority of patients (83%), which is in line with previous reports of excellent results in ~75% of patients 15 . The subjective improvement was accompanied by a significant improvement in somatosensory function for all detection thresholds except warm detection. A selectively impaired postoperative recovery of warm detection has previously been reported in patients with entrapment neuropathies including CTS 16 and lumbar radiculopathy 17 . Whereas this may be attributed to more subtle deficits in warm than cold detection in patients with CTS 18 , it may also be explained by a previously observed delayed functional recovery of unmyelinated C-fibres (encoding warm sensations) compared to Afibres 19, 20 .
At 6 months after surgery, there was a significant reinnervation of the skin by epidermal nerve fibres, however this remained incomplete. Given the relatively short reinnervation distance and the previously reported rate of axon regeneration 21 one may have expected a higher rate of reinnervation. However, this slow regeneration of small epidermal fibres is in line with previous animal work 22, 23 and experimental human studies 4, 5 . It has been suggested that the epidermal layer of the skin may be a relatively hostile environment for regenerating fibres as demonstrated by incomplete epidermal regeneration while dermal reinnervation is successful 7, 10 . Here, we could not find a postoperative increase in the subepidermal plexus length or number of dermal axon bundles. The available quantification methods may however not be sensitive to detect relatively subtle changes in dermal small fibres amidst the abundance of large fibres.
Alternatively, dermal reinnervation may indeed remain incomplete or only reach subdermal levels, as previously shown for SP+ axons (small peptidergic fibres) following experimental nerve injury 23 . The slow rate of reinnervation emphasizes the point that any future trials of agents to promote nerve regeneration in which epidermal nerve fibres are used as an outcome measure would need to be of significant duration.
Meissner corpuscle and dermal myelinated bundle density in CTS patients were comparable to controls at baseline and remained unaltered after surgery despite a clear improvement in large fibre function assessed by QST (mechanical and vibration detection thresholds). Presumably, the large fibre dysfunction in CTS is driven by ischaemic and demyelinating changes at the lesion site -as has been shown in experimental 24 and clinical nerve compression 25 -rather than axon degeneration and changes to target tissue receptors 9, 24 . This is supported by the significant albeit incomplete recovery of electrophysiological properties over the affected wrist segment following surgical decompression. Persistence of thin myelin sheets after remyelination as shown in experimental models 26, 27 may account for the continuing conduction slowing.
Unlike in a previous cohort 9 , patients with CTS did not have an increased nodal length at baseline. Since the presence of elongated nodes seems to be protective in nature 9 , this disparity may be caused by the inclusion of patients with more severe symptoms in the current presurgical cohort (not showing protective nodal elongation) compared to the patients with milder symptomatology in the previous cohort 9 . Of note, nodal length significantly increased following surgery, further corroborating a protective effect. The mechanism underlying the presence of elongated nodes remains speculative, but it could be associated with the dynamic process of demyelination or remyelination 28 . Given the increased presence of elongated nodes after surgery and their correlation with functional recovery, an association with remyelination seems more likely. Alternatively, it has been demonstrated that the incorporation of cytoskeletal and ion channel components to nodes of Ranvier requires vesicular transport 29 . It is therefore possible that the restoration of axon transport following carpal tunnel surgery enhances delivery of nodal components and nodal lengthening. Elongated nodes may also reflect nerve fibre lengthening during nerve regeneration, as has been shown in experimental limb lengthening in the rabbit 30 .
The axon and its associated Schwann cell are closely linked at the septate-like junction of the paranode. Lengthening may therefore be more easily achieved at the node rather than at the internode, which would require increased length of both axon and Schwann cell.
We identified a large degree of interindividual variation in the extent of small fibre regeneration and nodal changes, which correlate with clinical recovery. Currently, therapeutic targets that promote nerve regeneration in humans are lacking. Using CTS as a model system, we hypothesised that we could identify a transcriptional signature in the skin that would show a relationship to successful reinnervation by sensory axons. We identified ADCYAP1 as the most upregulated gene (3.7 fold change) using RNA-seq, and droplet digital PCR confirmed this upregulation. This increased expression was associated with histological evidence of neural regeneration. ADCYAP1 encodes PACAP (pituitary adenylate cyclase-activating peptide), which is a pleiotropic secreted molecule that has been associated with cell survival in neurodegenerative conditions 31 as well as growth cone guidance 32 and increased neurite outgrowth of peripheral afferent neurons in preclinical models 32, 33, 34, 35 . Animal studies have shown that PACAP is expressed in small to medium sized DRG neurons and upregulated during the regenerative process following nerve injury 36, 37 . In relation to localization, we could identify PACAP in sensory afferents in human skin. In terms of the source of this PACAP, it may be expressed by keratinocytes, released and subsequently bind to its receptor PAC1 (which we found was expressed on the growth cones of hiPSCd-sensory neurons). Alternatively, we also found that ADCYAP1 mRNA is expressed by hiPSCd-sensory neurons and so it may be having an autocrine action on these neurons.
Whereas a regenerative function of PACAP on sensory neurons has been demonstrated for central 38, 39 and peripheral neurons 33, 34, 35, 40 in animals, its effects on neurite outgrowth in human neurons has not previously been tested. One study reported that PACAP can rescue hiPSCdmotor neurons from apoptosis 31 . We found that administration of PACAP to hiPSCd-sensory neurons resulted in a large (70%) and significant increase in neurite outgrowth in vitro. It should be noted that we found a number of other genes significantly associated with cutaneous reinnervation (e.g., DLX1, PRKG2, ADHFE1, LINC01835, PIK361) and this dataset can therefore be further exploited to identify biomarkers of and therapeutic targets relating to neural regeneration in humans.
Due to the ethical consideration of not withholding treatment, and given that our primary aim was to determine nerve regeneration and its relationship to functional recovery, our study used a prospective cohort rather than a trial design of randomising patients to surgical intervention or conservative management. Nevertheless, we continued to follow up thirteen patients who decided not to undergo surgery. The small sample and the absence of randomisation with lower age and symptom severity in non-operated patients precludes a direct comparison. However, the progressive structural decline of small nerve fibres that we identified in this group is however intriguing, and the potential implications for management of these patients warrants further investigation.
We have shown that PACAP is significantly upregulated following cutaneous reinnervation and can promote axon outgrowth in a human sensory neuronal model. Exploitation of PACAP as a treatment to promote neural regeneration in vivo will require consideration of optimal delivery
given that systemic treatment can trigger migraine 41 . In fact, function blocking antibodies to PAC1 are undergoing clinical testing for migraine treatment 42 and given our findings, care will need to be taken that such treatments do not impair sensory neuron function in the context of coexisting neuropathy. One means of optimising delivery to promote neurite outgrowth of small fibres would be to develop small molecule agonists of PAC1 which can be given locally as has been achieved for other growth promoting molecules such as GDNF 43 .
Materials and Methods
Study Design
This study used a prospective longitudinal cohort design paired with in vitro experiments to determine the cellular and molecular correlates of nerve regeneration in humans. Seventy-three patients with clinically 44 and electrodiagnostically 45 46 for the primary outcome measure of small fibre regeneneration following surgery using previous data from the cross-sectional Oxford CTS cohort 9 . Fifty-nine patients were required to detect a 20% increase in IENFD with 80% power, significance set at α=0.05 and an effect size of 0.328. consequences of the study has been explained. Whereas the healthy participants only attended a single session, all patients (including those that did and did not undergo surgery) attended two appointments; one at baseline and a follow up appointment (~6 months after surgery/baseline appointment). In patients with CTS, the hand that was operated (surgery group) or the hand that was more affected (no-surgery group) was tested, whereas the non-dominant hand was tested in healthy controls. All clinical measurements were collected by the same experienced examiner to ensure consistency.
Symptom and function questionnaires
Patients with CTS completed the Boston Carpal Tunnel Questionnaire (symptom and function scale; 0 = no symptoms/disability, 5 = very severe symptoms/disability) 47 to determine symptom severity and functional deficits. Clinical recovery was determined with two global rating of change scales (GROC) 48 evaluating changes in hand symptoms and function. The GROC scales range from 'a very great deal better' (+7), to 'a very great deal worse' (-7). A change of 5 or more points (a good deal better/worse) is considered a clinically meaningful change 49 . In addition, we calculated the difference in the Boston questionnaire subscales (follow-up minus baseline).
Electrodiagnostic tests
Electrodiagnostic tests were performed with an ADVANCE system (Neurometrix, Waltham, MA, USA). Orthodromic sensory latencies and amplitudes were recorded over the digit to wrist segments for the median (index finger), ulnar (little finger) and superficial radial nerve (snuffbox) as previously described (9). Compound motor potentials (CMAP) were recorded over the abductor pollicis brevis and adductor digiti minimi by stimulating at the elbow as well as at the wrist. Radial CMAPs (extensor indicis proprius) were recorded by stimulating over the spiral groove. Electrodiagnostic testing was graded according to the scale by Bland 45 as mild (2), moderate (3), severe (4), very severe (5) or extremely severe (6) . To determine the presence of a very mild CTS (1), we included two sensitive tests: the presence of a 'double peak' during combined ulnar and median sensory stimulation at the ring finger and recording at the wrist 50 and the presence of prolonged lumbrical to interossei motor latency difference >0.4ms when measured over a fixed distance of 8cm 51 . Hand temperature was standardised to >31 degrees Celsius. During data analysis, absent sensory and motor recordings were replaced with values of zero for amplitudes but excluded from analysis of latencies and nerve conduction velocities to prevent inflated results.
Quantitative sensory testing (QST)
QST was performed according to the standardised protocol published by the German research network of neuropathic pain 52 
Histological analysis of target tissue
Skin biopsies
Two serial skin biopsies (3mm diameter) were taken 6 months apart on the ventrolateral aspect of the proximal phalanx of the index finger, innervated by the median nerve. The second biopsy was taken a few millimetres more proximal, avoiding the primary biopsy site. One surgical patient received Warfarin for unrelated reasons and no follow-up biopsy was thus taken. The biopsies were performed under sterile conditions following local anaesthesia with 1% lidocaine
(1-1.8ml). Whereas half of the skin biopsy was immediately snap frozen for transcriptional analysis (see below), the other half was fixed in fresh periodate-lysine-paraformaldehyde for 30 minutes before being washed in 0.1M phosphate buffer and cryoprotected in 15% sucrose in 0.1M phosphate buffer. After embedding in OCT, the tissue was frozen and stored at -80 degrees. To assure consistency, each histological analysis was performed by the same blinded observer.
Intraepidermal nerve fibre density (IENFD)
Fifty µm thin sections were cut on a cryostat and stained using a previously described protocol 9 .
Serial biopsies of the same patient were processed in the same batch to minimise variability.
Sections were blocked with 5% fish gelatine before incubation with the primary antibodies for myelin basic protein (MBP, Abcam, 1:500) and protein gene product 9.5 (PGP, Ultraclone, 1:1000) overnight. Secondary antibodies were also incubated overnight (Alexa 488 1:1000, Abcam; Cy3 Stratech 1:500). The PGP antibody from Ultraclone was discontinued during our study. Benchmarking revealed that the PGP antibody from Zytomed (1:200) provided comparable staining quality and epidermal nerve fibre counts in biopsies of the same patients, and was therefore used for subsequent analyses.
Intraepidermal nerve fibre density (IENFD) was established by counting 3 sections per participant down the microscope, while strictly adhering to established counting criteria 56 . Intrarater reliability to determine IENFD was examined by processing and counting n=23 skin samples twice, 1 week apart. Intraclass correlation coefficient revealed almost perfect intra-rater agreement for IENFD (ICC 2,1 0.913 (95% confidence interval 0.791-0.963), p<0.0001).
Myelinated fibre integrity
We used several approaches to evaluate myelinated fibre integrity. First, we quantified the number of Meissner corpuscles per mm epidermis as previously reported 9 . Second, dermal nerve bundles containing myelinated fibres were expressed as a ratio of total PGP 9.5+ nerve bundles containing at least five PGP+ axons per mm 2 dermis (excluding the subepidermal plexus). Third, we measured the length of nodes of Ranvier in the subepidermal plexus of MBP/PGP doublestained sections in up to 10 sections per participant. This was achieved with the Zen black software (Zeiss, UK) on confocal image stacks taken at 40x magnification as previously reported 9 . Nodes were classified as elongated if they exceeded 6.1µm in length 57 . If fewer than 15 nodes were identified, patients were excluded from the analysis (n=8).
Subepidermal plexus length
Estimation of nerve fibre length density in the subepidermal plexus was performed on PGP 
Statistical analysis of clinical and histological data
Data were analysed using SPSS (version 24, IBM) and R software 59 . Normal distribution of clinical and histological data was established by visual inspection and with the Kolmogorov-Smirnov test for normality.
The main statistical comparison concerned the pre-vs post-surgical data. This was achieved using two-sided paired t-tests or Wilcoxon signed rank tests for parametric and non-parametric data respectively. In order to establish differences at baseline and the extent of recovery, pre-and post-surgical data of patients with CTS were compared with healthy control data using two-sided independent t-tests or Mann Whitney U tests where appropriate. In order to control for false discovery rate (FDR) of multiple testing, Benjamini-Hochberg correction was applied for three comparisons with the false positive rate set to 5% 60 . Unadjusted p-values are reported for ease of interpretation. Data of non-operated patients were analysed and reported separately using the same statistical analyses as for operated patients.
Correlation of histological findings with changes in symptomatology/function
Spearman's correlation analyses were performed in the full patient cohort to determine 
Molecular analysis of target tissue
RNA sequencing
Half of the skin biopsies of 47 patients with CTS (n=29 females) before and after surgery were snap frozen in liquid nitrogen. RNA was extracted using a combination of phenol extraction and column purification. Samples were homogenized in Trizol and mixed with chloroform before spinning to induce phase separation. The aqueous liquid phase containing the nucleic acids was removed and added to the columns of the High Pure RNA tissue kit (Roche Diagnostics, UK).
RNA was purified using repeated wash steps and DNAse treatment. The extracted RNA was sent for sequencing at the Wellcome Trust Centre for Human Genetics in Oxford. All samples were normalised to 650ng prior to library preparation using the TruSeq Stranded Total RNA Library
Prep Kit (Illumina, UK) and poly-A enrichment. Paired-end sequencing was performed using the HiSeq4000 platform with a read length of 75bp.
RNA-sequencing data were mapped to the GRC.h.38 Human Genome using the STAR aligner 61 with the ENCODE standard options. Read counts were calculated at the gene level using HTSeq 62 and the ENSEMBL gene set annotation GRC.h.38.88. Raw counts were normalised using the effective library size, and for visualisations and associations with phenotypes they were transformed using the variance stabilising transformation (VST) in R using DESeq2 63 . Library size normalised gene counts were fitted to the negative binomial distribution and hypothesis testing was carried out using the Wald test. P-values were FDR corrected using the Benjamini-Hochberg procedure for multiple tests and the Independent Hypothesis Weighting (IHW) 64 . Gene ontology enrichment for biological processes for DE genes was carried out in R using topGO 65 and GSEA 66 . Hypothesis testing was performed using the weighted Fisher test and the significance cut-off was 0.01. The background gene list consisted of the 18068 genes expressed with > 0 counts in all samples.
Gene to regenerative phenotype association
Fold gene expression changes relative to baseline ((post-surgery -pre-surgery)/pre-surgery) and
individual baseline expression of significantly DE genes were tested for association with fold changes and post versus pre differences in IENFD and nodal length. This was achieved by testing significant Pearson correlation coefficients and by binning the continuous outcomes into four categories corresponding to the four quarters as defined by the outcome quartiles with significance assessed using one-way ANOVA. In all associations of gene expression or fold change to phenotype, significance cut-off was an FDR adjusted p-value < 0.05. Raw and processed RNA-sequencing as well as basic phenotype data has been uploaded onto dbGAP (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001796.v1.p1).
Droplet digital PCR to validate RNA sequencing
The findings of the RNA sequencing were validated in 78 paired samples pre and post surgery (n=39 patients) using digital droplet PCR (ddPCR). Complementary DNA was prepared using the Evoscript Universal cDNA Master kit (Roche Diagnostics, UK). TAQMAN assays (Thermo-Fisher, UK) for ADCYAP1 (Hs00174950_m1) and HPRT1 (Hs03929098_m1, reference) were run in duplicates with 1µl of target probe labelled with FAM added to 1µl of reference probe labelled with VIC in the same reaction using the ddPCR Supermix for Probes (Bio-Rad, UK).
QuantaSoft v1.7.4.0917 software (Bio-Rad Laboratories) was used to extract data (copies/µl) and normalised gene expression was reported (ratios of target over reference data).
Localisation of PACAP in skin biopsies
The localisation of PACAP (encoded by ADCYAP1) expression in skin biopsies was evaluated using an immunofluorescent staining protocol adapted from Hannibal et al 67 were incubated for 10 minutes in FITC conjugated tyramide (Perkin Elmer, 1:100) diluted in 0.1M Borate buffer containing 0.0003% hydrogen perioxide. After 3 washes, slides were coverslipped in mounting medium and imaged on a n Observer Z1 confocal imaging system (Zeiss).
In-vitro expression and role of ADCYAP1/PACAP
RNA-sequencing of hiPSCd-sensory neurons
We interrogated our data from a previous RNA sequencing experiment 68 in human fibroblastderived induced pluripotent stem cell-derived sensory neurons which were generated as previously described 13 . Sequencing was performed using the Illumina HiSeq4000 paired-end protocol with 75bp reads. Reads were mapped on the Hg38 (GRCh38) human genome using STAR with the default ENCODE options. Gene counts were calculated for the GRCh38.88 gene set annotation using HTSeq. Data is available in the GEO series GSE107181. We evaluated ADCYAP1 and its receptor PAC1 expression levels compared to other genes.
Differentiation of human induced pluripotent stem cell (iPSC)-derived sensory neurons
The iPSC line NHDF is a control line derived from a healthy 44-year-old female 69 . Dermal fibroblasts from this individual were purchased from Lonza (CC-2511) which were then used for reprogramming to pluripotency. Lonza provide the following ethics statement: 'These cells were isolated from donated human tissue after obtaining permission for their use in research applications by informed consent or legal authorization.' The human iPSCs derived from these fibroblasts were generated as control lines for part of a larger-scale project (Ethics committee:
NRES Committee South Central -Berkshire UK, REC 10/H0505/71). The fibroblasts were differentiated to sensory neurons as described previously 12, 13, 70 . In brief, cells were plated at high density following Versene EDTA (ThermoFisher) passaging. Neural induction was initiated in KSR medium (Knockout-DMEM, 15% knockout-serum replacement, 100 µM βmercaptoethanol, 1% nonessential amino acids 1%, Glutamax (ThermoFisher)) by dual SMAD inhibition (SB431542 (Sigma, 10 µM) and LDN-193189 (Sigma, 100 nM). Three additional small molecules were introduced on day 3: CHIR99021 (Sigma, 3 µM), SU5402 (R&D Systems, 10 µM) and DAPT (Sigma, 10 µM) and dual SMAD inhibitors were withdrawn on day 5. KSR medium was gradually transitioned in 25% increments to neural medium (N2/B27-Neurobasal medium, 2% B27 supplement, 1% N2 supplement, 1% Glutamax, (ThermoFisher)) over an 11day period. Cells were subsequently dissociated and replated onto glass coverslips in neural medium supplemented with growth factors at 25ng/ml (BDNF; ThermoFisher, NT3, NGF, GDNF; Peprotech). CHIR90221 was included for 4 further days, while SU5402 and DAPT were no longer included at this point. Phenol-free Matrigel (Corning, 1:300 dilution) was included from 25 days onward. Medium changes were performed twice weekly. Neurons were matured for 27±1 weeks before performing neurite outgrowth assays.
Human sensory neuron regeneration model
In order to determine a potential regenerative role of PACAP in human primary sensory neurons, we dissociated mature hiPSCd-sensory neurons and assessed their ability to regenerate neurites, as we have previously described 14 . Neurons were enzymatically treated for 30 min with 0.1% Trypsin (ThermoFisher), followed by mechanical dissociation with a fire polished glass pipette.
Single cells were re-plated onto matrigel treated coverslips at low density in the presence of 10nM PACAP protein (AnaSpec) or 0.01% DMSO (Sigma), before fixation and analysis by immunocytochemistry 18 hours later.
Quantification of neurite outgrowth
One differentiation of mature hiPSCd-sensory neurons was used for all studies. 1 μm increase following surgery and remain higher than healthy controls. Significant differences for paired/independent t-tests after Benjamini Hochberg correction are indicated between groups with #p<0.05 ##p<0.01 ###p<0.0001 and within groups with **p<0.01 ***p<0.0001. Group differences based on n=59 patients with CTS and n=20 healthy controls. (I) A more pronounced intraepidermal nerve fibre regeneration (Difference IENFD) correlates with improved symptoms (r=0.389, p=0.001, difference Boston symptom scale data multiplied with -1). (J) The correlation between difference in mean nodal length and the global rating of change scale (GROC) for hand function marginally fails to reach significance after Benjamini Hochberg correction (r=0.316, p=0.008). Y-axis shows RNA-seq log2 normalised gene counts. Boxplots show the median and interquantile range with single data points depicting each experiment (n=3 cell lines, 2 differentiation each). (C) Immunohistochemical staining of hiPSCd-sensory neurons demonstrating expression of the PACAP receptor (PAC1, green) in the soma as well as at the growth cones (5x magnified inset). (D) PACAP given to dissociated mature and re-plated hiPSCd-sensory neurons enhances neurite outgrowth compared to vehicle. Data is quantified with mean and standard error of measurements in (F), **=p=0.008
